Investors
Global commercialisation strategy
IP protection
Our IP platform provides the opportunity to commercialise and develop unique, best-in-class products for a broad range of pain mitigation and wound care indications in livestock, companion animals and humans globally.
Partnering and business development
Partnering and business development is integral to our strategy of becoming a leader in wound care pain mitigation.
We have several strong and creative partnerships with innovative companies, contract manufacturing organisations and research institutions that have advanced, and continue to advance, our business.
Our technology
Medi-Solfen has a proven platform technology and is focused on building a strong product portfolio within the field of wound care pain mitigation. Medi-Solfen will consider out-licensing development and marketing rights to successful companies once key clinical milestones have been achieved.
Partnership opportunities
To explore partnership opportunities, please contact our Business Development Team at: BDM@medicalethics.me
Read more
See our investment highlights to date, and understand more about our use of funds, and R&D investment in our Corporate Profile document
